Current of injury predicts adequate active lead fixation in permanent pacemaker/defibrillation leads.

Saxonhouse SJ, Conti JB, Curtis AB.
 J Am Coll Cardiol, 2005;45:412-417.

Ventricular reverse remodeling and 6-month outcome in patients receiving cardiac resynchronization therapy: Analysis of the MIRACLE Study.

Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JM, Curtis AB.
 J Interv Card Electrophysiol 2005; 12:107-113. 

Azithromycin for the secondary prevention of coronary events.

Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, and Knirsch C for the ACES Investigators. Curtis AB: member, Data and Safety Monitoring Board)
 N Engl J Med 2005;352:1637-1645.

Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.

Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber D, Slee A, the AFFIRM Investigators. Am Heart J, 2005;149:304-308.

The AFFIRM Investigators. Clinical factors that influence response to treatment strategies in atrial fibrillation: The AFFIRM Study.

 (Curtis AB, facilitator of writing group)
Am Heart J 2005;149:645-649.

Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.

Day JD, Curtis AB, Epstein AE, Goldschlager NF, Olshansky B, Reynolds DW, Wang PJ.
 Heart Rhythm, 2005:2:1161-1163.

Images in cardiovascular medicine: dense right sided hemiparesis in a 36 year old woman.

Cutro RG, Geiser E, Curtis AB.  
  Circulation, 2005:112:e67.

Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE Study).

Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, Pires LA for the PAVE Study Group.
J Cardiovasc Electrophysiol 2005;16:1160-1165.

Management of heart failure after cardiac resynchronization therapy: Integrating advanced heart failure treatment with adequate device function.

Aranda JM Jr, Woo GW, Schofield RS, Handberg EM, Hill JA, Curtis AB, Sears SF, Goff JS, Pauly DF, Conti JB.
J Am Coll Cardiol 2005;46:2193-2198.

Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: results of over two thousand patients from a multicenter study program.

Leon AR, Abraham W, Curtis A, Daubert J, Fisher W, Gurley J. J Am Coll Cardiol 2005;46:2348-2356.

CRT 101: If It’s Not Late, Pacing It Early Won’t Help,
Curtis AB.
 J Am Coll Cardiol 2005;45:70-71.

Arrhythmias during pregnancy.

Conti JB, Curtis AB.
In: Saksena S, Camm AJ, eds. Electrophysiological Disorders of the Heart: Philadelphia, PA, Elsevier, Inc., 517-532, 2005.

Cardiac Arrhythmias and Electrophysiology Self-Assessment Program (ArrhythmiaSAP)

Curtis AB, Burkart TA, eds.
 CD-ROM, Windows. Bethesda, MD: American College of Cardiology, 2005.

Antiarrhythmic drugs.

Reiffel JA, Curtis AB.
In: Curtis AB, Burkart TA, eds. ArrhythmiaSAP. CD-ROM, Windows. Bethesda, MD: American College of Cardiology, 2005.

Disorders of sinus and AV nodal conduction and syncope

Grubb BP, Curtis AB.
 In: Curtis AB, Burkart TA, eds. ArrhythmiaSAP. CD-ROM, Windows. Bethesda, MD: American College of Cardiology, 2005.

Ventricular arrhythmias and sudden cardiac death

Curtis AB, Epstein AE, Wilber DJ.
In: Curtis AB, Burkart TA, eds. ArrhythmiaSAP. CD-ROM, Windows. Bethesda, MD: American College of Cardiology, 2005.

Cardiac arrhythmias and electrophysiology.

Curtis AB, ed.
 In: Lewis RP, O’Gara TP, Parmley, WW, eds. Adult Clinical Cardiology Self-Assessment Program (ACCSAP) 6. Bethesda, MD: American College of Cardiology; 6th ed, 15.1-15.135, 2005.

Antiarrhythmic drugs.

Reiffel JA, Curtis AB.
In: Lewis RP, O’Gara TP, Parmley, WW, eds. Adult Clinical Cardiology Self-Assessment Program V. Bethesda, MD: American College of Cardiology; 6th ed, 15.53-15.63, 2005.

Disorders of sinus and AV nodal conduction and syncope.

Grubb BP, Curtis AB.
In: Lewis RP, O’Gara TP, Parmley, WW, eds. Adult Clinical Cardiology Self-Assessment Program V. Bethesda, MD: American College of Cardiology; 6th ed, 15.25-15.35, 2005.

Ventricular arrhythmias and sudden cardiac death.

Curtis AB, Epstein AE, Wilber DJ.
In: Lewis RP, O’Gara TP, Parmley, WW, eds. Adult Clinical Cardiology Self-Assessment Program V. Bethesda, MD: American College of Cardiology; 6th ed, 15.117-15.135, 2005.

New insights into implantable cardioverter defibrillators and cardiac resynchronization therapy: who benefits?

Curtis AB.
Medscape Cardiology, New York, NY, December 20, 2004, 1747 words. Available at: http://www.medscape.com/viewarticle/496076.

Practice point commentary on the DINAMIT Trial – Hohnloser SH et al. (2004) Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction.

Curtis AB.
Nature Clinical Practice Cardiovascular Medicine, 2005;2, 192-193.

Update on cardiac device therapy from the American College of Cardiology Annual Scientific Sessions.

April 15, 2005, 2465 words.
Curtis AB.
 Available at: http://www.medscape.com/viewarticle/502894.

The defibrillation safety margin of patients receiving ICDs: a matter of definition.

Barold SS, Herweg B, Curtis AB.
 PACE, 2005;28:881-882..

Letter to the editor: reply.
Steinberg JS, Arshad A, Rozanski A, Shedd OL, and Curtis AB.
 J Am Coll Cardiol 2005;45:1733.

Loss of resynchronization by biventricular pacemakers: Mechanism, diagnosis and therapy.

Barold SS, Herweg B, Curtis AB.
In: Raviele A, ed. Cardiac Arrhythmias 2005: Proceedings of the 9th International Workshop on Cardiac Arrhythmias (Venice, 2-5 October 2005), New York: Springer, 531-545, 2005.

The importance of minimizing right ventricular pacing in patients with sick sinus syndrome: why and how?

Curtis AB, Barold SS, Herweg B.
In: Raviele A, ed. Cardiac Arrhythmias 2005: Proceedings of the 9th International Workshop on Cardiac Arrhythmias (Venice, 2-5 October 2005), New York: Springer, 557-568, 2005.

Experience counts: better patient outcomes with higher device volumes.

Curtis AB.
 J Am Coll Cardiol, 2005;46:1541-1542.

Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients with Left Ventricular Dysfunction.

Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM,
J Am Coll Cardiol 2006;47:456-63.

The effect of management of anticoagulation in a specialty anticoagulation clinic versus a primary care physician’s office on the maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation.

Cutro R Jr, Burkart TA, Curtis AB.
 Clin Cardiol, 2006;29-78-82.

ICD Implant-Explant-Implant Case Study:  Addressing the Psychological Adjustment to Multiple Shocks.

Kovacs AH, Feigofsky S, Goff JS, Saidi AS, Curtis AB, Conti JB, Sears SF.
Clin Cardiol, 2006;29:274-276.

Latency during left ventricular pacing from the lateral epicardial cardiac veins: a cause of ineffective biventricular pacing in patients with cardiomyopathy.

Herweg B, Ilercil A, Madramootoo C, Krishnan S, Rinde-Hoffman D, Weston M, Curtis AB, Barold SS. PACE 2006;29:574-581.

Mechanical esophageal deflection during ablation of atrial fibrillation.
Herweg B, Johnson N, Postler G, Curtis AB, Barold SS, Ilercil A.
 PACE 2006;29:957-961.

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).
European Heart Rhythm Association and the Heart Rhythm Society; Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. J Am Coll Cardiol. 2006;48:854-906. Also J Am Coll Cardiol. 2006;4:e149-246.

Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines.

Carlson MD, Wilkoff BL, Maisel WH, Ellenbogen KA, Saxon LA, Prystowsky EN, Alpert JS, Cain ME, Ching EA, Curtis AB, Davies DW, Hammill SC, Hauser RG, Lampert R, Zipes DP.. Heart Rhythm 2006;3:1250-1272.

Oral amiodarone prophylaxis reduces atrial tachyarrhythmia following cardiac surgery.

Curtis AB, Singh D.
Evidence-based Cardiovasc Med 2006;10:141-143.

Electrocardiographic diagnosis of myocardial infarction and ischemia during cardiac pacing.

Barold SS, Herweg B, Curtis AB.
 Cardiol Clin 2006;24:387-399.

Diagnostic value of the 12-lead electrocardiogram during conventional and biventricular pacing for cardiac resynchronization.

Barold SS, Herweg B, Giudici MC, Curtis AB.
Cardiol Clin 2006;24:471-490.

Should all defibrillators be implanted by electrophysiologists?

Curtis AB.
 ACCEL 2006;38:10.

Why ICD implantation might not be the best idea for your elderly patient.

Yarnoz M, Curtis AB.
Am J Geriatric Cardiol 2006;15:367-371.

Clustering of ventricular arrhythmias: a therapeutic opportunity or strictly a marker of poor prognosis?

Curtis AB.
J Cardiovasc Electrophysiol 2006;17:1307-1309.

Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.

Yarnoz M, Curtis AB.
Cardiol Review 2006;14:292-298.

Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention?

Curtis AB.
J Interv Card Electrophysiol 2006;17:169-175..

Defibrillator implantation without induction of ventricular fibrillation: good enough?

Curtis AB.
Circulation 2007;115:2370-72..

New driving recommendations for patients with primary prevention ICDs.

Curtis AB.
EP Lab Digest May 2007;7:1,10.

Preventing Tomorrow’s Sudden Cardiac Death Today Part I: Current Data on Risk Stratification for Sudden Cardiac Death.

Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fair E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky MA, Hohnloser S, Kim RJ, Lee K, Mark DB, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W.
Am Heart J 2007;153:941-50.

Preventing Tomorrow’s Sudden Cardiac Death Today: Part II: Translating Sudden Cardiac Death Risk Assessment Strategies into Practice and Policy.

Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee K, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R. Am Heart J 2007;153:951-9.

American Heart Association Addendum to: Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the Heart Rhythm Society: Public Safety Issues in Patients with Implantable Defibrillators.

Epstein AE, Baessler C, Curtis AB, Estes NAM; Blair Grubb B, Gersh B, Mitchell LB, Vetter V.               
Circulation 2007;115:1170-6.

CT and massive pulmonary embolism. Cardiosource Web Site, American College of Cardiology Foundation.

Khan H, Barbier GP, Curtis AB.
Available at http://www.cardiosource.com/casestudies/casestudy.asp?studyid=1017.

Improving the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting: The IMPROVE HF Performance-Improvement Registry.

Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gattis Stough W, Gheorghiade M, Heywood JT, Mehra M, O’Connor CM, Reynolds D, and Walsh MN. Am Heart J 2007.154:12-38.

Tumor Necrosis Factor- Reduces Argininosuccinate Synthase Expression and Nitric Oxide Production in Aortic Endothelial Cells

Bonnie Goodwin, Laura Pendleton, Monique Levy, Larry Solomonson, and Duane Eichler

Am J Physiol Heart Circ Physiol (May 11, 2007). doi:10.1152/ajpheart.01100.2006  

A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial

Dimitri Novitzkya, A Laurie Shroyerb, Joseph F Collinsc, Gerald O McDonaldd, John Luckee, Brack Hattlerb, Elizabeth Kozorab, Douglas D Bradhamc, Janet Baltz b and Frederick L Grover b

for the VA #517 Randomized On/Off Bypass (ROOBY) Study Group

CLICK HERE TO SEE PUBLICATION

Aldosterone antagonists : the most underutilized class of heart failure medications.

Guglin M, Esmaeel Awad K, Polavaram L, Vankayala H.

Am J Cardiovasc Drugs. 2007;7(1):75-9.

Erythropoietin: New Horizon in Cardiovascular Medicine.

Koul D,  Dhar S,  Chen-Scarabelli C,  Guglin M,  Scarabelli  T.

Recent Patents on Cardiovascular Drug Discovery 2007; 2(1):5-12

Electrical storm in hemodialysis: A story of death reversed 65 times.

Guglin M,   Kumaravelu P.

Dialysis & Transplantation  2007;36(3):128 - 133

Therapeutic potential of vasopressin receptor antagonists.

Ali F, Guglin M, Vaitkevicius P, Ghali JK.

Drugs. 2007;67(6):847-58.